National Bank of Canada’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,000
| Closed | -$22.4K | – | 2742 |
|
|
2024
Q2 | $22.4K | Buy |
1,000
+500
| +100% | +$11.2K | ﹤0.01% | 1782 |
|
|
2024
Q1 | $12.2K | Buy |
500
+475
| +1,900% | +$11.6K | ﹤0.01% | 1937 |
|
|
2023
Q4 | $770 | Hold |
25
| – | – | ﹤0.01% | 2384 |
|
|
2023
Q3 | $728 | Buy |
25
+10
| +67% | +$291 | ﹤0.01% | 2392 |
|
|
2023
Q2 | $611 | Hold |
15
| – | – | ﹤0.01% | 2428 |
|
|
2023
Q1 | $559 | Hold |
15
| – | – | ﹤0.01% | 2438 |
|
|
2022
Q4 | $523 | Sell |
15
-685
| -98% | -$23.9K | ﹤0.01% | 2471 |
|
|
2022
Q3 | $39K | Buy |
+700
| New | +$39K | ﹤0.01% | 1617 |
|
|
2022
Q2 | – | Sell |
-239
| Closed | -$17K | – | 2666 |
|
|
2022
Q1 | $17K | Sell |
239
-50
| -17% | -$3.56K | ﹤0.01% | 1998 |
|
|
2021
Q4 | $34K | Buy |
+289
| New | +$34K | ﹤0.01% | 1779 |
|